Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Ingresos
22,971
22,971
22,419
21,601
19,705
17,905
Crecimiento de los Ingresos (YoY)
2%
2%
4%
10%
10%
24%
Costo de los ingresos
5,600
5,600
5,329
5,281
5,036
4,447
Utilidad bruta
17,371
17,371
17,090
16,320
14,669
13,458
Venta, General y Administración
12,016
10,732
10,136
9,515
9,241
8,706
Investigación y Desarrollo
1,401
1,345
1,347
1,176
1,261
1,091
Gastos de Operación
13,417
13,447
12,785
11,868
11,569
9,915
Otras Ingresos (Gastos) No Operativos
--
-224
-216
-165
-132
-133
Ingreso antes de impuestos
3,101
3,101
3,716
3,745
2,927
3,461
Gasto por Impuesto a la Renta
734
734
824
922
651
750
Ingreso Neto
1,545
1,545
2,387
1,795
2,082
2,513
Crecimiento de la Utilidad Neta
-35%
-35%
33%
-14%
-17%
124%
Acciones en Circulación (Diluidas)
211.06
211.31
217.22
223.13
226.01
234.82
Cambio de Acciones (YoY)
-2%
-3%
-3%
-1%
-4%
-2%
EPS (Diluido)
7.31
7.31
10.98
8.04
9.21
10.7
Crecimiento de EPS
-34%
-33%
37%
-13%
-14%
129%
Flujo de efectivo libre
3,321
3,321
3,488
3,616
1,722
2,717
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
75.62%
75.62%
76.22%
75.55%
74.44%
75.16%
Margen de operación
17.21%
17.08%
19.2%
20.61%
15.73%
19.78%
Margen de beneficio
6.72%
6.72%
10.64%
8.3%
10.56%
14.03%
Margen de flujo de caja libre
14.45%
14.45%
15.55%
16.73%
8.73%
15.17%
EBITDA
--
5,443
5,740
5,786
4,276
4,608
Margen de EBITDA
--
23.69%
25.6%
26.78%
21.7%
25.73%
D&A para EBITDA
--
1,519
1,435
1,334
1,176
1,065
EBIT
3,954
3,924
4,305
4,452
3,100
3,543
Margen de EBIT
17.21%
17.08%
19.2%
20.61%
15.73%
19.78%
Tasa de Impuesto Efectiva
23.66%
23.66%
22.17%
24.61%
22.24%
21.67%
Estadísticas clave
Cierre Anterior
$36.53
Precio de apertura
$36.53
Rango del día
$36.53 - $36.53
Rango de 52 semanas
$31.85 - $43.77
Volumen
71
Volumen promedio
106
EPS (TTM)
1.96
Rendimiento de dividendos
--
Cap. de mercado
$7.8B
¿Qué es WILLF?
Demant A/S engages in the development, manufacture, and sale of products and equipment designed to aid the hearing and communication of individuals. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The firm operates globally, through more than 90 subsidiaries and associates worldwide.